Archer-Daniels-Midland Company

🇺🇸New York Stock Exchange
Back to all articles
Archer-Daniels-Midland Company stock analysis ADM overview
Somewhat Bullish +50

BMO Capital Adjusts ADM Estimates, Notes Margin Recovery in March

📈 BMO Capital analyst Andrew Strelzik raised the price target on ADM stock to $65 from $63 while maintaining a Market Perform rating.

💹 Margin recovery in March was driven by updated feedstock prices, higher energy costs, and improved U.S. beef margins after a softer February.

📅 Chairman Juan Luciano expects adjusted EPS for 2026 to range between $3.60 and $4.25 based on current guidance.

💰 CFO Monish Patolawala highlighted plans to stay disciplined with capital allocation focused on cash flow generation and cost reduction.

🎯 The company is on track to achieve total cost savings of $500 million to $750 million over a three- to five-year period starting in 2025.

💸 Capital expenditures for 2026 are projected to fall between $1.3 billion and $1.5 billion according to executive estimates.

🌾 Crush margins for the first quarter of 2026 are expected to remain in line with Q4 2025 performance levels.

🥛 The Nutrition segment is anticipated to continue improving both year over year and sequentially into the next quarter.

🏭 ADM operates as a global agricultural supply chain manager linking local demand with processing capabilities.

⚠️ An external source suggests AI stocks may offer higher returns than ADM, though this contradicts the positive analyst outlook on agricultural margins.

💡 The firm's broader note focused on Agribusiness and Protein commodities reflecting improved operating environment expectations.

Bullish Signals
  • BMO Capital analyst Andrew Strelzik raised the price recommendation on Archer-Daniels-Midland Company (NYSE: ADM) from $63 to $65, signaling growing analyst confidence in the stock.
  • The firm noted a recovery in U.S. beef margins in March following weaker levels in February, reflecting an improving operating environment for commodities.
  • CEO Juan Luciano expects adjusted EPS for 2026 to be between $3.60 and $4.25, providing clear forward-looking guidance on profitability.
  • CFO Monish Patolawala highlighted that earlier clarity on policy decisions could unlock more opportunities as the company anticipates a more supportive operating environment.
  • The company is committed to staying disciplined in capital allocation to generate strong cash flow while continuing its cost reduction initiatives.
  • Management expects total cost savings of $500 million to $750 million over a three- to five-year period, with the program having started in 2025.
  • Capital expenditures are planned in the range of $1.3 billion to $1.5 billion in 2026, demonstrating controlled investment levels alongside efficiency gains.
  • Crush margins for Q1 2026 are expected to remain on par with Q4 2025 levels, indicating stability in core processing operations.
  • The Nutrition segment is projected to continue improving both year-over-year and sequentially, driving growth in high-value product lines.
Risk Factors
  • The price recommendation from BMO Capital was raised only marginally to $65 from $63, with the firm maintaining a neutral 'Market Perform' rating rather than a stronger bullish stance.
  • CEO Juan Luciano provided guidance for 2026 adjusted EPS in a relatively narrow band of $3.60 to $4.25, which may not fully meet elevated market expectations for growth.
  • The company plans to allocate capital expenditures in the range of $1.3 billion to $1.5 billion in 2026, raising questions about whether this level of spending is sustainable given current margin pressures.
  • Crush margins are expected to remain flat at Q4 2025 levels for the first quarter of 2026, indicating a lack of immediate improvement in core processing profitability despite earlier recovery notes.
  • The article suggests ADM offers less investment promise compared to certain AI stocks and does not appear to have 10,000% upside potential like those highlighted alternatives.
Full Analysis
BMO Capital analyst Andrew Strelzik raised the price recommendation on Archer-Daniels-Midland Company (NYSE: ADM) to $65 from $63, maintaining a Market Perform rating as of March 25. This adjustment was part of a broader note on agribusiness and protein commodities, reflecting updated feedstock prices and higher energy costs. A key factor in the revision was a recovery in U.S. beef margins observed in March following weaker performance in February. The firm noted that its models have been adjusted to account for these commodity price shifts. On Q4 2025 earnings, CEO Juan Luciano stated that the company expects adjusted earnings per share (EPS) for 2026 to range between $3.60 and $4.25. Chief Financial Officer Monish Patolawala highlighted that clearer policy decisions could present additional opportunities within a more supportive operating environment. The company remains committed to capital discipline, focusing on strong cash flow generation and cost reduction. Specifically, ADM is targeting total cost savings of $500 million to $750 million over the next three to five years as part of a program launched in 2025. Looking forward, ADM anticipates crush margins for the first quarter of 2026 to remain in line with Q4 2025 levels, while the Nutrition segment is expected to show continued improvement both year-over-year and sequentially. Capital expenditures are projected to fall between $1.3 billion and $1.5 billion for 2026. The company continues its role as a global agricultural supply chain manager, linking local demand with global capabilities and providing nutrition solutions for humans and animals. This strategic outlook supports the analyst's revised price target amidst the sector's evolving margin dynamics. The article concludes with promotional content from Insider Monkey regarding other investment opportunities, including claims about AI stocks and blockchain equities, though these statements are separate from the core financial analysis of ADM. The text includes disclosures stating none exist, alongside references to the firm's subscription model and historical returns through February 2026. These elements serve as editorial context rather than part of the fundamental earnings assessment provided by BMO Capital.